# Johnson & Johnson to acquire Abiomed in $16.6B deal

Johnson & Johnson agreed to acquire heart-support device maker Abiomed through a tender offer at $380 per share in cash plus a contingent value right of up to $35 per share, an enterprise value of about $16.6 billion.

- Type: Acquisition
- Announced: 2022-11-01
- Value: $16.6B
- Status: announced
- Products: heart recovery and support devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Johnson & Johnson](https://endata.com/companies/9845.md) (acquirer)
- [Abiomed](https://endata.com/companies/9846.md) (target)

## Sources

- [jnj.com](https://www.jnj.com/media-center/press-releases/johnson-johnson-to-acquire-abiomed), 2022-11-01: "Johnson & Johnson will acquire through a tender offer all outstanding shares of Abiomed, for an upfront payment of $380.00 per share in cash, corresponding to an enterprise value of approximately $16.6 billion"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.